Results 191 to 200 of about 271,177 (332)

Clinical commissioning of a novel compact multi-room pencil beam scanning proton therapy system. [PDF]

J Appl Clin Med Phys
Lee E, Faught AM, Lee HA, Batin E, Ayan A.   +4 more
europepmc   +1 more source

Clinical results of proton beam therapy for advanced neuroblastoma

, 2013
OOSHIRO Yoshiko, MIZUMOTO Masashi, OKUMURA Toshiyuki, Sugahara Shinji, FUKUSHIMA Takashi, ISHIKAWA Hitoshi, Nakao Tomohei, HASHIMOTO Takayuki, TSUBOI Koji, Ohkawa Haruo, KANEKO Michio, SAKURAI Hideyuki   +11 more
openalex   +1 more source

Proton GRID treatment planning on a compact proton therapy delivery system

Jufri Setianegara, Tom Mazur, Xin Zhao, Tao Zhang, Michael Watts, F. Pak, Justin M. Barnes, Stephen Perkins, Shahed N. Badiyan, Michael T. Prusator, Tianyu Zhao   +10 more
openalex   +1 more source

PO-0940 The effects of Bragg curve degradation in proton therapy of bronchial carcinomas

, 2019
Veronika Flatten, Kilian‐Simon Baumann, Uli Weber, Stefan Lautenschläger, Fabian Eberle, Rita Engenhart‐Cabillic, Klemens Zink   +6 more
openalex   +1 more source

CRISPR/Cas9‐Based Vanadium MXene‐Free Radical Spatiotemporally Controlled Nanoreactor for Photothermal‐Induced Multi‐Effect Synergistic Antitumor Therapy

Advanced Science, EarlyView.
In this study, a MXene‐based V4C3 nanoplatform, VARH, was constructed, which achieved a photothermal conversion efficiency of 44.21% in the NIR‐II window. This platform integrated photothermal therapy, chemodynamic therapy, and thermodynamic therapy with CRISPR/Cas9‐mediated heat shock protein 90 knock‐out technology.
Zi‐Jian Huang, Feng‐Ming Li, Yi‐Fan Tu, Ke‐Ke Feng, Cheng‐Lei Li, Shi‐Cheng Tian, Yong‐Shan Hu, Jing‐Wei Shao, Zhen‐Hua Liu   +8 more
wiley   +1 more source

Relative Biological Effectiveness-Clinical Practice at US Proton Therapy Centers. [PDF]

Int J Part Ther
Lühr A, Mohan R, Mahajan A, Shih HA, Paganetti H.   +4 more
europepmc   +1 more source

ALKBH3 m1A Demethylase Deficiency Reduces Alzheimer's Amyloid‐β Pathology

Advanced Science, EarlyView.
This study identifies that ALKBH3‐driven m1A demethylation orchestrates Alzheimer's disease progression by disrupting mitochondrial and synaptic homeostasis. This epitranscriptomic mechanism suppresses PINK1‐mediated mitophagy via m1A erasure, leading to mitochondrial dysfunction, oxidative stress, elevated Aβ production, and impaired microglial ...
Yueyang Li, Sifei Yu, Kaidong Lu, Yujie Zhang, Mingjie Dong, Yan Peng, Liang Xue, Waleed Alam, Yuxuan Shui, Yi Zhou, Wuyunhan Ma, Meng Bao, Peiming Li, Peiyi Luo, Tiezhan Lu, Jiajia Li, Kang Zhang, Yuying Wang, Shuchen Yang, Nuoya Yin, Francesco Faiola, Zilong Gao, Jingfeng Zhou, Fei Zhao, Yali He, Magdalena J. Koziol   +25 more
wiley   +1 more source

Nanomedicine Meets Immunotherapy: Advancing Adoptive Cell Therapy with Nanoparticles in the Treatment of Cancer with Sustainability Perspectives

Advanced Science, EarlyView.
This review surveys nanoparticle‐based strategies to enhance adoptive cell therapy, particularly CAR‐T cell approaches, in solid tumor treatment. It describes how nanoparticles can improve tumor immunogenicity and T‐cell infiltration while reducing toxicity, and how they enable in vivo CAR‐T cell generation.
Erica Frostegård, Tatiana Bobrova, Amalie Leinebø, Thibault Leray, Shayamita Ghosh, Lorena García‐Hevia, Chiara Puccinelli, Lorenzo Riccio, Jacopo Sorani, Davide Bonifazi, Julien Caumartin, Emmanuel Donnadieu, Florence Gazeau, Roland Hischier, Else Marit Inderberg, Mónica L. Fanarraga, Maria Loustau, Bernd Nowack, Sébastien Wälchli, Cécilia Ménard‐Moyon   +19 more
wiley   +1 more source

Imaging, automation and workflow challenges for online adaptive proton therapy. [PDF]

Phys Imaging Radiat Oncol
Wagenaar D, Albertini F, Muren LP, Knäusl B.   +3 more
europepmc   +1 more source

DUAL ENERGY COMPUTED TOMOGRAPHY FOR PROTON THERAPY TREATMENT PLANNING

, 2011
Ming Yang
openalex   +1 more source